Johnson Matthey (LON:JMAT – Get Free Report)‘s stock had its “buy” rating reaffirmed by investment analysts at Jefferies Financial Group in a research note issued on Thursday, Digital Look reports. They presently have a GBX 2,770 price objective on the stock. Jefferies Financial Group‘s price target points to a potential upside of 15.22% from the company’s current price.
Separately, Berenberg Bank boosted their target price on Johnson Matthey from GBX 2,300 to GBX 2,550 and gave the stock a “buy” rating in a report on Wednesday, October 28th. Four research analysts have rated the stock with a Buy rating and one has given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of GBX 2,458.
Get Our Latest Research Report on JMAT
Johnson Matthey Stock Down 0.1%
JMAT stock opened at GBX 2,404 on Thursday. Johnson Matthey has a twelve month low of GBX 2,192 and a twelve month high of GBX 3,245.33. The company has a quick ratio of 0.76, a current ratio of 1.56 and a debt-to-equity ratio of 69.69. The firm has a market cap of £2.98 billion, a PE ratio of -31.52, a price-to-earnings-growth ratio of 49,242.50 and a beta of 0.88. The business has a 50 day moving average of GBX 2,388.53 and a 200 day moving average of GBX 2,156.39.
Insider Buying and Selling at Johnson Matthey
In other Johnson Matthey news, insider Liam Condon acquired 10,951 shares of Johnson Matthey stock in a transaction that occurred on Friday, September 11th. The stock was bought at an average cost of GBX 2,306 per share, for a total transaction of £252,530.06. Also, insider Richard Pike acquired 12 shares of Johnson Matthey stock in a transaction that occurred on Wednesday, November 11th. The stock was acquired at an average price of GBX 2,433 per share, with a total value of £291.96. Insiders have purchased 28,628 shares of company stock worth $64,999,052 over the last ninety days. 0.78% of the stock is currently owned by insiders.
About Johnson Matthey
Johnson Matthey is a global leader in science that enables a cleaner and healthier world. With over 200 years of sustained commitment to innovation and technological breakthroughs, they improve the function, performance and safety of their customers’ products. Their science has a global impact in areas such as low emission transport, pharmaceuticals, chemical processing and making the most efficient use of the planet’s natural resources. Today more than 13,000 Johnson Matthey professionals collaborate with their network of customers and partners to make a real difference to the world around us.
See Also
- Five stocks we like better than Johnson Matthey
- Checkmate for AI Chips? NVIDIA’s Crisis Opens the Board
- Can NVIDIA Maintain Its Momentum Without Huang?
- Six Flags Lost $366 Million in Q3—Its Insiders Just Went Shopping
- What Went Wrong With Amprius Technologies’ Q3? Less Than You’d Think
Receive News & Ratings for Johnson Matthey Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson Matthey and related companies with MarketBeat.com's FREE daily email newsletter.
